Correlation Between Access Blood Flow and Extracorporeal Blood Flow

NCT ID: NCT00522704

Last Updated: 2014-11-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-03-31

Study Completion Date

2015-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if Effective Extracorporeal Blood Flow(eEBF) has correlation with Access Blood Flow (Qa), when eEBF adjusts with Dynamic Arterial Line Pressure (DALP) in patients with Arteriovenous fistulae in hemodialysis treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Accesses that show a large (\>15%) decrement over time in vascular access blood flow are associated with a high risk of thrombosis. Serial measurements of vascular access blood flow predict access thrombosis. At the moment, the measurement of access flow is time consuming, operator dependent, so that it cannot be done with every treatment. We hypothesized that extracorporeal blood flow at pressure of -200 to -260 mmHg in arterial line has correlation with access blood flow and this can be used to estimate access blood flow.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Arteriovenous Fistula

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dynamic Arterial line Pressure (DALP)

eEBF will be record with dynamic arterial line pressure of -60 mmHg (eEBF-60 mmHg), -100 mmHg (eEBF-100 mmHg), -160 mmHg (eEBF-160 mmHg), -200 mmHg (eEBF-200 mmHg) and -260 mmHg (eEBF-260 mmHg) during the first one half hour of the dialysis session. Access Blood flow will be performed with blood thermal monitor.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

BTM,

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with Chronic Kidney Disease K-DIGO 5d in hemodialysis treatment)
* Permanent vascular accesses with native arteriovenous fistulas (AVF)
* AVF that were at least 12 weeks old

Exclusion Criteria

* Inflammation and pain in AVF
* Negation to participate in the study
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

JOSE CARRASCO ARTEAGA HOSPITAL FROM Ecuadorian Institute of Social Security

UNKNOWN

Sponsor Role collaborator

Instituto Nacional de Cardiologia Ignacio Chavez

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

FRANKLIN MORA

Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Franklin B Mora, M.D.

Role: PRINCIPAL_INVESTIGATOR

HOSPITAL JOSE CARRASCO ARTEAGA DEL INSTITUTO ECUATORIANO DE SEGURIDAD SOCIAL REGIONAL 3

Luis R Mariscal, M.D.

Role: STUDY_CHAIR

Instituto Nacional de Cardiología Ignacio Chávez

Guadalupe C De la Cruz, R.N.

Role: STUDY_CHAIR

Instituto Nacional de Cardiología Ignacio Chávez

Héctor G Pérez-Grovas, M.D.

Role: STUDY_CHAIR

Instituto Nacional de Cardiología Ignacio Chávez

Fabián H Ortiz, MsC

Role: PRINCIPAL_INVESTIGATOR

Hospital Clínica Kennedy, Guayaquil Ecuador

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Instituto Nacional De Cardiología Ignacio Chávez

Mexico City, Distrito Federeal, Mexico

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Mexico

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Franklin B Mora, M.D.

Role: CONTACT

593 72 868084

Luis R Mariscal, M.D.

Role: CONTACT

52 55 55 7932911 ext. 1262

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Luis R Mariscal, M.D.

Role: primary

52 55 557932911 ext. 1262

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

INCich-07-08-7403

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.